NASDAQ | CashCropToday
GW Pharma’s New Compound GWP42006 Fails Initial Trial Testing
Health
265 views
Health
265 views

GW Pharma’s New Compound GWP42006 Fails Initial Trial Testing

Editor - February 22, 2018

On February 21, 2018 GW Pharmaceuticals PLC (Nasdaq:GWPH) (“GW,”) announced that a Phase 2a proof of concept study of a pipeline compound GWP42006 in adult patients with…